The Cholesterol Myth: Why Cholesterol Isn’t the Real Cause of Heart Disease
What Really Causes Heart Disease: Inflammation, Insulin Resistance, and the Truth About Statins
For decades, cholesterol has been portrayed as the primary cause of heart disease. This belief—often referred to as the cholesterol myth—has shaped decades of medical guidelines focused on lowering LDL cholesterol and reducing dietary fat.
Despite this approach, cardiovascular disease remains the leading cause of death in the United States, responsible for one death every 33 seconds—even as more than 40 million Americans take statin medications daily (1).
During the same period, the cholesterol-lowering drug market has expanded to exceed $19 billion annually, yet cardiovascular mortality has not declined proportionally (2).
As a result, many people questioning statins, cholesterol myths, or persistent cardiovascular risk despite “normal” labs are beginning to ask a deeper question.
This article examines the biological role of cholesterol, why cholesterol-lowering strategies alone have failed to reduce heart disease at the population level, and which metabolic and inflammatory processes more accurately predict cardiovascular risk.
Is Cholesterol Really the Cause of Heart Disease?
Cholesterol alone does not cause heart disease. Atherosclerosis develops when inflammation, oxidative stress, and metabolic dysfunction damage lipoproteins—particularly oxidized LDL—which then trigger immune responses within the arterial wall. These processes are strongly influenced by insulin resistance, diet quality, and metabolic health.
Why Cholesterol Alone Does Not Explain Heart Disease Risk
Heart disease continues to account for roughly one in five deaths nationwide, despite decades of cholesterol-focused treatment strategies and dietary guidance (1,3).
These outcomes suggest that cholesterol levels alone do not adequately explain heart disease risk or cardiovascular disease development.
Current evidence indicates that atherosclerosis and cardiovascular disease are driven by a complex interaction of metabolic dysfunction, chronic inflammation, oxidative stress, insulin resistance, liver and bile physiology, mitochondrial health, and autonomic nervous system regulation—processes that are not captured by standard lipid panels.
A more effective framework for cardiovascular care requires understanding and addressing these upstream biological drivers rather than focusing exclusively on cholesterol reduction.
→ Functional & Integrative Medicine
Myth #1: Cholesterol Causes Heart Disease
For decades, cholesterol has been cast as the primary villain behind heart disease. However, this framing oversimplifies cardiovascular biology and does not accurately reflect how atherosclerosis and heart disease actually develop.
Atherosclerosis is now understood to be a chronic inflammatory process involving endothelial injury, immune activation, and the accumulation of modified lipoproteins within the arterial wall.
Why Cholesterol Is Essential for Hormones, Brain Health, and Cell Function
Cholesterol is a vital substance the body depends on continuously. It is required for:
Production of steroid hormones, including estrogen, testosterone, cortisol, and progesterone
Synthesis of vitamin D, which supports immune regulation, bone integrity, and cardiovascular function
Formation of bile acids, essential for fat digestion and cholesterol elimination through the liver (4,5)
Cholesterol is also a fundamental structural component of cell membranes. In the brain, it is critical for neuronal membrane integrity, synapse formation, learning, and memory (6).
Cholesterol itself is not harmful. The problem lies in how lipoproteins behave under conditions of metabolic stress.
The Real Cardiovascular Risk: Oxidized LDL and Small, Dense LDL Particles
LDL cholesterol is not a uniform particle. Cardiovascular risk is influenced not only by LDL concentration but also by the number of atherogenic lipoprotein particles, often measured through apolipoprotein B (ApoB). Cardiovascular risk is driven by lipoprotein quality and modification, not total cholesterol concentration alone.
Research shows that higher cardiovascular risk is associated with:
Small, dense LDL particles, which more readily penetrate the arterial wall
Oxidized LDL, which triggers endothelial injury, immune activation, and inflammatory plaque formation within the arterial wall. (7)
These pathological changes are strongly influenced by insulin resistance, chronic inflammation, oxidative stress, poor diet quality, environmental toxic exposures, and broader metabolic dysfunction—rather than by total cholesterol levels in isolation.
These factors influence how LDL particles behave in the bloodstream and whether they remain stable or become oxidized and atherogenic.
Myth #2: Lower Cholesterol Is Not Always Better
Lower cholesterol is not inherently better. In some cases, very low cholesterol levels may increase health risks, particularly when cholesterol suppression interferes with hormone production and neurological function.
Why Cholesterol Is Critical for Hormones, Brain Function, and Nervous System Health
Cholesterol is not merely a circulating fat molecule—it is a foundational component of normal endocrine function. It is also a critical structural component of cell membranes, helping maintain membrane stability, cellular signaling, and communication between tissues throughout the body.
The body requires cholesterol to synthesize critical hormones, including:
Estrogen
Testosterone
Cortisol
Progesterone
When cholesterol levels drop too low, hormone production can be impaired. Clinically, this may contribute to fatigue, mood disturbances, sleep disruption, reduced stress tolerance, reproductive dysfunction, and symptoms associated with adrenal imbalance.
Low total cholesterol has also been associated in research with increased risk of depression, anxiety, hemorrhagic stroke, certain cancers, and cognitive decline in some populations (7).
Why Cholesterol Is Essential for Hormones, Brain Function, and Nervous System Health
The brain contains roughly 20–25% of the body’s total cholesterol, where it plays a critical role in myelin formation, neuronal signaling, and synapse stability.
In older adults, higher cholesterol levels are often associated with better memory, preserved cognitive function, and increased longevity (6). Rather than being uniformly harmful, cholesterol may play a protective or adaptive role as the body ages, particularly within the nervous system.
These findings challenge the assumption that cholesterol should be driven as low as possible across all ages and health contexts and highlight that cholesterol is not merely a cardiovascular risk marker but an essential biological molecule required for normal hormonal, neurological, and cellular function.
Myth #3: Statins Are Not Risk-Free
Statins are commonly prescribed as a first-line intervention for elevated LDL cholesterol. While they are effective at lowering LDL levels, they are not universally benign nor equally beneficial for all individuals.
Statins: Benefits, Risks, and Potential Side Effects
Statins reduce cholesterol synthesis by inhibiting HMG-CoA reductase. This enzyme is part of the mevalonate pathway, a metabolic pathway responsible not only for cholesterol synthesis but also for the production of several molecules essential for mitochondrial function and cellular signaling. As a result, statins lower LDL cholesterol but may also influence other important cellular processes.
Reported and well-documented statin-associated effects include:
Muscle pain, weakness, or reduced exercise tolerance
Elevations in liver enzymes
Cognitive symptoms such as memory changes or brain fog
Increased risk of type 2 diabetes, particularly in older adults and women (9,11)
Statins also reduce endogenous production of Coenzyme Q10 (CoQ10), a key component of mitochondrial electron transport required for cellular energy production and cardiac muscle function (19). Given the heart’s exceptionally high energy demand, prolonged CoQ10 depletion may impair mitochondrial efficiency and cardiac resilience over time.
Reduced CoQ10 availability may contribute to mitochondrial dysfunction in skeletal muscle, which is one proposed mechanism behind statin-associated muscle symptoms.
In patients without established cardiovascular disease, statins often provide modest absolute risk reduction for primary prevention of heart disease, while leaving key drivers of cardiovascular risk—such as insulin resistance, inflammation, oxidative stress, and metabolic dysfunction—largely unaddressed.
Additionally, several commonly prescribed cardiovascular and metabolic medications may contribute to nutrient depletion, potentially worsening fatigue, muscle symptoms, and metabolic strain if not recognized and corrected.
Myth #4: Cholesterol Numbers Alone Predict Heart Disease Risk
Standard lipid panels measure cholesterol concentration, but they often provide a limited and sometimes misleading assessment of heart disease risk and overall cardiovascular health.
Traditional cholesterol testing focuses primarily on total cholesterol, LDL cholesterol, and HDL cholesterol. While these markers provide useful information, they do not fully capture the metabolic, inflammatory, and genetic factors that drive atherosclerosis.
Markers That Predict Heart Disease Risk More Accurately Than Cholesterol Alone
More clinically meaningful indicators of cardiovascular risk reflect lipoprotein particle behavior, inflammation, endothelial function, genetic risk factors, and metabolic health rather than total cholesterol levels alone. These include:
LDL particle size and density
Small, dense LDL particles more easily penetrate the arterial wall, become oxidized, and trigger immune activation involved in plaque formation.Apolipoprotein B (ApoB)
A protein present on all atherogenic lipoproteins, including LDL and VLDL. ApoB reflects the total number of cholesterol-carrying particles in circulation and is considered a more accurate predictor of cardiovascular risk than LDL cholesterol concentration alone.LDL particle size and particle number (LDL-P)
Small, dense LDL particles more easily penetrate the arterial wall, become oxidized, and trigger immune activation involved in plaque formation.High-sensitivity C-reactive protein (hs-CRP)
A marker of systemic inflammation strongly associated with endothelial injury and atherosclerotic progression.Lipoprotein(a) [Lp(a)]
A genetically determined lipoprotein associated with increased clotting tendency, arterial inflammation, and elevated cardiovascular risk independent of LDL cholesterol. Lp(a) levels are largely inherited and are not detected through standard lipid panels.Homocysteine
An amino acid associated with impaired methylation, endothelial dysfunction, and increased oxidative stress. Elevated homocysteine levels are linked to higher risk of atherosclerosis, stroke, and cardiovascular disease.Fasting insulin and the triglyceride-to-HDL ratio
Sensitive indicators of insulin resistance, a major driver of dyslipidemia, endothelial dysfunction, and metabolic disease. A high triglyceride-to-HDL ratio often reflects impaired metabolic health and increased cardiovascular risk. (10).
When these markers are abnormal, cardiovascular risk may be substantial—even when total cholesterol appears “normal.” Conversely, people with elevated cholesterol but low inflammatory burden and preserved metabolic function often demonstrate lower actual cardiovascular risk.
Coronary Artery Calcium (CAC): A Direct Measure of Plaque
While blood markers help estimate cardiovascular risk, imaging can provide direct evidence of atherosclerotic plaque within the arteries.
The coronary artery calcium (CAC) score, obtained through a specialized CT scan, measures calcified plaque within the coronary arteries. Higher CAC scores correlate with increased plaque burden and a greater risk of future cardiovascular events. A CAC score of zero generally indicates very low short-term cardiovascular risk, while progressively higher scores reflect increasing plaque burden.
Unlike standard cholesterol tests, CAC imaging evaluates the actual presence of atherosclerosis, rather than estimating risk indirectly through circulating biomarkers.
For some patients—particularly those with uncertain risk profiles or conflicting laboratory markers—a CAC score can provide valuable clarity when deciding how aggressively to pursue cardiovascular prevention strategies.
However, CAC testing does not replace metabolic evaluation. Atherosclerosis develops through long-term interactions between inflammation, lipoprotein behavior, metabolic dysfunction, and vascular injury. Imaging and laboratory testing together provide the most complete understanding of cardiovascular risk.
This highlights a critical limitation of cholesterol-centric screening and underscores the need for a more comprehensive, systems-based risk assessment.
→ Advanced Functional Lab Testing
Myth #5: Low-Fat Diets Prevent Heart Disease
Low-fat dietary guidelines were promoted as a cornerstone of heart disease prevention for decades. Yet cardiovascular disease rates remain high, while obesity, type 2 diabetes, and metabolic syndrome have risen dramatically.
Why Low-Fat Diets Can Worsen Metabolic Health and Cardiovascular Risk
The low-fat paradigm did not fail because people ignored it—it failed because it targeted the wrong variable.
When fat is removed from the diet, it is almost universally replaced with:
Refined carbohydrates
Added sugars
Processed grains
Industrial seed oils
This dietary shift predictably worsens metabolic health and cardiometabolic risk. High carbohydrate intake raises triglyceride levels, which are strongly associated with insulin resistance and the formation of small, dense LDL particles—lipoprotein patterns closely linked to atherosclerosis. Excess carbohydrate intake can also drive de novo lipogenesis, a metabolic process in which the liver converts excess glucose into fatty acids and triglycerides.
These metabolic changes also increase oxidative stress and endothelial injury, mechanisms directly associated with the development of cardiovascular disease (5,10).
Elevated triglycerides are often accompanied by reduced HDL cholesterol, producing a high triglyceride-to-HDL ratio—an indicator of insulin resistance and increased cardiovascular risk.
Dietary fat was never the primary driver of heart disease—metabolic dysfunction is.
Dietary fats from whole, unprocessed sources are essential for hormone production, cellular integrity, and glycemic regulation. Eliminating them while increasing refined carbohydrates and industrial oils destabilizes metabolic signaling and increases cardiovascular risk rather than reducing it.
The health effects of dietary fat depend heavily on the overall dietary context. Whole-food sources of fat—such as eggs, dairy, meat, olive oil, nuts, and avocados—behave very differently metabolically than fats consumed alongside refined carbohydrates and ultra-processed foods.
This misunderstanding of dietary fat laid the foundation for decades of concern about saturated fat, which became one of the most controversial topics in cardiovascular nutrition.
Myth #6: Saturated Fats Should Be Avoided
Saturated fat has been blamed for heart disease for decades. This conclusion was drawn from early observational research that failed to control for sugar intake, smoking, processed food consumption, and overall metabolic health.
The Physiological Role of Saturated Fat in Human Health
Higher-quality contemporary research does not consistently support a causal relationship between saturated fat intake and cardiovascular disease in metabolically healthy populations (10).
Saturated fats play essential roles in normal human physiology, including:
Supporting sex hormone and adrenal hormone synthesis
Strengthening and stabilizing cell membranes
Supporting larger, less atherogenic LDL particle patterns, which are less likely to penetrate the arterial wall than small, dense LDL particles.
Facilitating absorption of fat-soluble vitamins A, D, E, and K (5)
Saturated fat is not a single entity. Source and food context matter. Saturated fats consumed from whole, unprocessed foods—such as grass-fed meats, pasture-raised eggs, dairy, coconut, and cacao—behave differently in the body than fats consumed alongside refined carbohydrates and industrial processing.
The primary dietary drivers of cardiovascular risk are:
Refined carbohydrates
Industrial seed oils (such as canola, soybean, and corn oil)
Ultra-processed foods
The issue is not saturated fat itself. It is food quality, processing, and metabolic context. The metabolic effects of dietary fats are strongly influenced by the overall food matrix, meaning the combination of nutrients, fiber, and bioactive compounds present in whole foods.
This confusion about saturated fat also fueled concern about cholesterol-rich foods, leading to decades of warnings against foods such as eggs and shellfish.
Myth #7: Dietary Cholesterol Raises Blood Cholesterol and Causes Heart Disease
Foods high in cholesterol—such as eggs, shellfish, and organ meats—have long been discouraged based on the belief that dietary cholesterol directly raises blood cholesterol and increases heart disease risk. This assumption does not reflect how human cholesterol regulation actually works.
Why Dietary Cholesterol Has Little Effect on Blood Cholesterol
For most people, dietary cholesterol has little effect on circulating blood cholesterol levels (10). Cholesterol levels are tightly regulated by the liver through a feedback system that adjusts endogenous production and LDL receptor activity based on dietary intake.
When dietary cholesterol intake increases, hepatic cholesterol synthesis decreases. When intake is low, the liver compensates by producing more. This regulatory mechanism maintains relative stability in healthy physiology.
Cholesterol-rich whole foods—including eggs, shellfish, and organ meats—are among the most nutrient-dense foods available. They provide:
Choline, essential for liver function and brain health
B vitamins that support mitochondrial energy metabolism
Fat-soluble vitamins critical for hormonal, immune, and cellular signaling
Targeting these foods diverts attention away from the dietary patterns that actually contribute to cardiovascular risk.
What Actually Causes Diet-Related Heart Disease Risk
Heart disease is not driven by dietary cholesterol intake. It is driven by diet-induced metabolic stress.
The primary dietary contributors include:
Refined sugars
Highly processed grains and flours
Industrial trans fats
Inflammatory seed oils such as canola, soybean, and corn oil
These inputs promote insulin resistance, oxidative stress, chronic inflammation, and unfavorable lipoprotein changes—conditions that damage lipoproteins and promote LDL oxidation, the form of LDL associated with plaque formation and arterial injury (10).
Bottom line:
Cholesterol-rich whole foods are not the problem.
Ultra-processed, industrialized foods are.
These misunderstandings about dietary cholesterol also contributed to the belief that medications are the only effective way to control cholesterol levels.
Myth #8: Statins Are the Only Way to Lower Cholesterol
Statins are often positioned as the default response to high cholesterol levels. This framing ignores the fact that cholesterol balance is regulated by multiple interconnected metabolic and physiological systems.
Why High Cholesterol Often Reflects Deeper Metabolic Imbalance
Statins lower LDL cholesterol by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol synthesis in the liver. This approach changes a laboratory value, but it does not address why cholesterol regulation became abnormal in the first place.
In many cases, elevated cholesterol reflects underlying dysfunction such as:
Insulin resistance
Chronic inflammation
Impaired bile flow and hepatic clearance
Mitochondrial inefficiency
Nutrient deficiencies affecting lipid metabolism
When these drivers are addressed, cholesterol levels and lipid patterns often improve without the need to suppress essential biological pathways. Diet quality, physical activity, weight regulation, sleep, and metabolic health all influence cholesterol metabolism and cardiovascular risk.
Cholesterol balance is closely linked to bile production and elimination, which represents one of the body’s primary pathways for removing excess cholesterol from the liver.
Genetic factors, including lipoprotein(a) and inherited lipid disorders, can also influence cholesterol patterns and cardiovascular risk.
Addressing these underlying drivers often requires a combination of nutrition, lifestyle support, and targeted therapeutic strategies.
Evidence-Based Strategies That Support Healthy Cholesterol Levels
A growing body of evidence supports targeted strategies that address the metabolic context of cholesterol regulation, including:
Berberine, which improves insulin sensitivity and lipid metabolism (15)
Artichoke leaf extract and bitter compounds, which support bile flow and cholesterol clearance (18,20)
Omega-3 fatty acids (EPA/DHA), which reduce inflammation and triglycerides (18)
Coenzyme Q10, which supports mitochondrial and cardiac energy production (19)
Red yeast rice, when used judiciously and under clinical supervision (17)
These approaches focus on restoring metabolic balance rather than suppressing cholesterol production as a primary goal.
Myth #9: High Blood Pressure and Cholesterol Are Unrelated
High blood pressure and cholesterol are often treated as unrelated clinical problems. In reality, they are frequently shaped by the same underlying metabolic and inflammatory processes.
Why High Blood Pressure and Cholesterol Often Share the Same Root Causes
Hypertension and abnormal cholesterol patterns commonly arise from shared dysfunction rather than independent causes.
Insulin resistance, chronic inflammation, oxidative stress, and autonomic nervous system imbalance impair endothelial function, disrupt lipid metabolism, and increase vascular tone simultaneously. When these processes are present, both blood pressure regulation and cholesterol metabolism become disrupted.
The endothelium—the thin layer of cells lining blood vessels—plays a central role in cardiovascular regulation. It regulates vascular tone through nitric oxide signaling, modulates inflammatory activity within the arteries, and influences the movement of lipoproteins across the vessel wall. Healthy endothelial cells continuously produce nitric oxide, a molecule that allows arteries to relax and maintain normal blood pressure.
When endothelial function is impaired, blood vessels become less able to dilate, blood pressure rises, and LDL particles are more likely to penetrate the arterial wall and contribute to plaque formation. This is why endothelial dysfunction is considered a key link between hypertension and atherosclerosis.
Over time, endothelial dysfunction and chronic inflammation contribute to arterial stiffness, reducing the ability of blood vessels to expand and increasing both blood pressure and cardiovascular strain. This loss of arterial flexibility increases vascular resistance and contributes to elevated blood pressure.
As metabolic health improves, cholesterol patterns and blood pressure often improve together, reflecting correction of the underlying physiology rather than isolated symptom control (13,14,17,18).
This is why long-term cardiovascular resilience depends less on targeting numbers in isolation and more on addressing metabolic regulation, vascular health, and nervous system balance.
Strategies That Support Both Blood Pressure and Cholesterol Levels
Evidence-supported strategies that influence both blood pressure and lipid regulation include:
Acupuncture — supports parasympathetic (“rest-and-digest”) activity, reduces stress-hormone signaling, and has been shown to lower both systolic and diastolic blood pressure (13).
Magnesium, potassium, and CoQ10 — help regulate vascular tone, support cardiac rhythm, and sustain mitochondrial energy production in cardiac muscle (18).
Herbal Support
Hawthorn — supports circulation and vascular tone
Garlic — supports blood pressure regulation and lipid balance
Hibiscus — shown to lower blood pressure in clinical studies
Olive leaf extract — supports arterial flexibility and has anti-inflammatory effects (14,17,18)
Daily movement — improves insulin sensitivity, circulation, and autonomic balance.
Nasal breathing and vagus nerve support — practices such as nasal breathing, cold exposure, chanting, and meditation activate vagal tone, helping lower heart rate and blood pressure while improving stress resilience.
Myth #10: LDL Is the “Bad” Cholesterol and HDL Is the “Good” Cholesterol
Cholesterol is often simplified into two categories: LDL cholesterol labeled as “bad” and HDL cholesterol labeled as “good.” While this framework is commonly used in basic health education, it oversimplifies how lipoproteins function in the body and how cardiovascular disease actually develops.
Why the “Good vs. Bad Cholesterol” Model Is Oversimplified
LDL and HDL are not types of cholesterol themselves—they are lipoproteins, particles that transport cholesterol, triglycerides, and fat-soluble molecules through the bloodstream.
LDL (low-density lipoprotein) carries cholesterol from the liver to tissues throughout the body, where it is used for hormone production, cell membrane structure, and other essential biological functions.
HDL (high-density lipoprotein) helps transport excess cholesterol from peripheral tissues back to the liver through a process known as reverse cholesterol transport.
Both lipoproteins play necessary roles in normal physiology.
Cardiovascular risk is influenced far more by lipoprotein behavior and metabolic context than by simple labels of “good” or “bad.”
What Actually Makes LDL Dangerous
LDL becomes problematic primarily when LDL particles undergo structural changes caused by metabolic stress.
Research shows that atherosclerosis is more strongly associated with specific lipoprotein changes, including:
• Small, dense LDL particles — which more easily penetrate the arterial wall
• Oxidized LDL — which triggers immune activation and inflammatory plaque formation
• Elevated ApoB particle counts — reflect the total number of circulating atherogenic lipoproteins and are considered a stronger predictor of cardiovascular risk than LDL cholesterol alone.
These changes are strongly influenced by insulin resistance, chronic inflammation, oxidative stress, and poor metabolic health.
HDL Function Matters More Than HDL Levels
HDL is often described as “protective,” but higher HDL cholesterol levels do not automatically translate into lower cardiovascular risk.
What matters more is HDL function, including its ability to:
• Participate in reverse cholesterol transport
• Reduce oxidative stress within blood vessels
• Support anti-inflammatory signaling within the endothelium
Under conditions of chronic inflammation or metabolic dysfunction, HDL particles can become dysfunctional, losing many of their protective properties.
A Better Way to Assess Cholesterol and Cardiovascular Risk
Rather than focusing solely on LDL and HDL levels, cardiovascular risk is better understood by evaluating:
• Lipoprotein particle size and number
• Oxidized LDL and inflammatory markers
• Insulin resistance and metabolic health
• Endothelial function and vascular inflammation
In this context, cholesterol itself is not the primary problem. The underlying metabolic environment determines whether lipoproteins remain stable and protective or become contributors to arterial injury and atherosclerosis.
A Functional Medicine Approach to Cholesterol and Heart Health
A functional medicine approach does not attempt to correct cholesterol numbers in isolation. Cholesterol patterns are viewed as signals of underlying physiology, not the primary problem to suppress.
Instead, the focus is on identifying why cholesterol regulation has shifted, including:
Altered cholesterol production or clearance
The role of inflammation and insulin resistance
Liver and bile pathway function
Mitochondrial health and nutrient status influencing cardiac performance
These factors influence how cholesterol is produced, transported, oxidized, and cleared from the body.
When these upstream factors are addressed, cardiovascular health can often improve without interfering with essential biological processes or relying solely on cholesterol suppression.
Rethinking Cholesterol and Heart Disease Risk
Cholesterol is not the primary driver of heart disease it has often been portrayed to be. It is a necessary biological molecule involved in hormone production, cellular integrity, and neurological function. Problems arise not from cholesterol itself, but from the metabolic, inflammatory, and regulatory imbalances that alter how cholesterol is produced, modified, and cleared.
Understanding cholesterol within this broader physiological context allows for a more accurate assessment of cardiovascular risk—one that moves beyond fear-driven narratives and focuses on the underlying processes that shape long-term heart health. These processes include inflammation, insulin resistance, endothelial dysfunction, lipoprotein particle behavior, and metabolic health.
A functional medicine approach emphasizes identifying and addressing these root drivers rather than focusing solely on cholesterol suppression.
A Thoughtful Next Step in Understanding Your Cardiovascular Risk
If you’ve been questioning your current approach to cardiovascular health, or wondering whether cholesterol numbers alone are telling the full story, a more comprehensive review may be helpful.
You may request a free 15-minute consultation with Dr. Martina Sturm to review your health concerns and outline appropriate next steps within a root-cause, systems-based framework.
Frequently Asked Questions About Cholesterol, Statins, and Heart Disease
Does high cholesterol actually cause heart disease?
High cholesterol alone does not automatically cause heart disease. Cholesterol is an essential molecule used to build hormones, cell membranes, and vitamin D. Cardiovascular disease develops when metabolic dysfunction, inflammation, oxidative stress, and endothelial damage alter how lipoproteins behave in the bloodstream. Factors such as insulin resistance, small dense LDL particles, and chronic inflammation often play a larger role in plaque formation than total cholesterol levels alone.
Can you have heart disease even if your cholesterol is normal?
Yes. Many people develop cardiovascular disease despite having normal cholesterol levels on standard lipid panels. Traditional cholesterol tests measure cholesterol concentration but do not assess inflammation, insulin resistance, endothelial function, or lipoprotein particle size. These factors strongly influence cardiovascular risk and may be abnormal even when cholesterol numbers appear normal.
What type of cholesterol actually contributes to plaque buildup?
Plaque formation is most strongly associated with small, dense LDL particles and oxidized LDL. These forms of LDL are more likely to penetrate the arterial wall and trigger inflammatory immune responses that lead to plaque development. The total number of atherogenic lipoproteins, often reflected by ApoB levels, is also an important predictor of cardiovascular risk.
Are statins the only way to lower cholesterol?
Statins are one approach to lowering LDL cholesterol, but they are not the only strategy. Cholesterol metabolism is influenced by diet quality, insulin sensitivity, inflammation, liver function, bile production, and metabolic health. Addressing these underlying drivers can often improve lipid patterns naturally while supporting overall cardiovascular health.
Is saturated fat actually bad for your heart?
Current research does not show a clear causal relationship between saturated fat intake and heart disease in metabolically healthy populations. The health effects of saturated fat depend heavily on food quality and overall diet. Whole-food sources of saturated fat behave very differently metabolically than fats consumed within ultra-processed foods or diets high in refined carbohydrates.
Does eating cholesterol raise blood cholesterol levels?
For most people, dietary cholesterol has little impact on blood cholesterol levels. The liver regulates cholesterol production through feedback mechanisms that adjust synthesis based on dietary intake. When dietary cholesterol increases, the liver typically reduces its own cholesterol production to maintain balance.
What lab tests provide a better picture of heart disease risk?
A more comprehensive cardiovascular assessment may include markers such as ApoB, lipoprotein(a), high-sensitivity C-reactive protein (hs-CRP), fasting insulin, triglyceride-to-HDL ratio, and homocysteine. These markers provide insight into inflammation, metabolic health, lipoprotein particle behavior, and genetic risk factors that are not captured by standard cholesterol testing.
What is a coronary artery calcium (CAC) score?
A coronary artery calcium score is a specialized CT scan that measures calcified plaque within the coronary arteries. Unlike blood tests, CAC imaging evaluates the actual presence of atherosclerosis. Higher CAC scores indicate greater plaque burden and increased cardiovascular risk.
Why do inflammation and insulin resistance increase heart disease risk?
Chronic inflammation and insulin resistance damage blood vessel walls, disrupt endothelial function, and alter lipoprotein metabolism. These processes promote oxidation of LDL particles and increase the likelihood of plaque formation within arteries, making them key drivers of cardiovascular disease.
Can cholesterol improve when metabolic health improves?
Yes. When insulin resistance, inflammation, liver function, sleep quality, and diet improve, cholesterol metabolism often improves as well. Addressing these root drivers can lead to healthier lipoprotein patterns and improved cardiovascular risk markers without focusing on cholesterol numbers alone.
Still Have Questions?
If the topics above reflect ongoing symptoms or unanswered concerns, a brief conversation can help clarify whether a root-cause approach is appropriate.
Resources
Centers for Disease Control and Prevention – Heart disease facts and statistics in the United States
Growth Plus Reports – Global cholesterol-lowering drugs market size and forecast
Journal of the American Heart Association – Statin utilization trends and expenditures in the United States before and after the 2013 ACC/AHA guidelines
StatPearls Publishing – Cholesterol physiology and metabolism
National Institutes of Health – Fat-soluble vitamins: dietary sources, absorption, and health implications
Journal of Neurology, Neurosurgery & Psychiatry – Better memory functioning associated with higher total and LDL cholesterol in very elderly subjects without the apolipoprotein E4 allele
Endocrine Reviews – Cellular cholesterol delivery and intracellular processing for steroid hormone biosynthesis
Biochimica et Biophysica Acta (Molecular and Cell Biology of Lipids) – Regulation of bile acid and cholesterol metabolism by PPARs
American Journal of Clinical Nutrition – Dietary cholesterol and the lack of evidence for cardiovascular disease risk
U.S. Food and Drug Administration – Cholesterol, statins, and cardiovascular risk communication
Hypertension – Randomized controlled trial of acupuncture for the treatment of hypertension
Frontiers in Pharmacology – Herbal medicines for cardiovascular diseases: efficacy, mechanisms, and safety
Journal of Ethnopharmacology – Traditional herbal remedies in cardiovascular disorders
Critical Reviews in Food Science and Nutrition – Therapeutic potential of spices in cardiovascular health
Journal of the American College of Cardiology – Supplemental vitamins and minerals in cardiovascular disease prevention and treatment
Current Cardiology Reviews – Coenzyme Q10 in cardiovascular and metabolic diseases
Circulation – Insulin resistance, inflammation, and cardiovascular disease risk
Diabetes Care – Triglyceride-to-HDL ratio and insulin resistance as predictors of cardiovascular risk